Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology

Launched by NANTES UNIVERSITY HOSPITAL · Jun 14, 2017

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patient (male and female) aged not more than 90 years old
• • Patients with neuropathy identified by EDX exam or small fibre neuropathy identified from a skin biopsy.
• • Patients who have undergone the minimal assessment for neuropathy as defined by the HAS (French National Health Authority): biological analysis (fasting glucose, CBC, liver and renal functions, CRP, pituitary TSH)
• • Patients belonging to the social security system
• • Patient who gave written informed consent
• • NON-INCLUSION CRITERIA Patients under legal supervision or guardianship Patients with a confirmed documented diagnosis of the cause of neuropathy Patients with evidence of Charcot Marie Tooth neuropathy: very slowly progressive course, pes cavus.
• • Patients who have already been investigated for a TTR mutation Pregnant women Minors